Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?

Radiology

Volumn 267, Issue 1, 2013, Pages 86-93

  Lacquaniti, Antonio ^a   Buemi, Francesco ^a   Lupica, Rosaria ^a   Giardina, Claudio ^a   Murè, Gabriella ^a   Arena, Adriana ^a   Visalli, Carmela ^a   Baldari, Sergio ^a   Aloisi, Carmela ^a   Buemi, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; BICARBONATE; CREATININE; GADOTERATE MEGLUMINE; IODINATED CONTRAST MEDIUM; IOMEPROL; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN RADICAL; SODIUM CHLORIDE; TECHNETIUM 99M;

ADULT; AGE; AGED; ALKALINIZATION; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFORMED CONSENT; INTERMETHOD COMPARISON; KIDNEY SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RADIATION DOSE; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RENAL PROTECTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; URINE LEVEL;

ACETYLCYSTEINE; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CREATININE; DIAGNOSTIC IMAGING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GELATINASES; GLOMERULAR FILTRATION RATE; HUMANS; IOPAMIDOL; KIDNEY DISEASES; LIPOCALINS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SODIUM BICARBONATE; SODIUM CHLORIDE;

EID: 84875461190     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120578     Document Type: Article

References (22)

1. McCullough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003;4(suppl 5):S3-S9.
2. Wessely R, Koppara T, Bradaric C, et al. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention. Circ Cardiovasc Interv 2009;2(5):430-437.
3. Brezis M, Rosen S. Hypoxia of the renal medulla: its implications for disease. N Engl J Med 1995;332(10):647-655.
4. Liss P, Nygren A, Erikson U, Ulfendahl HR. Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 1998;53(3): 698-702.
5. Harjai KJ, Raizada A, Shenoy C, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008;101(6): 812-819.
6. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 2008;23(12):2151-2157.
7. Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol 2007;156:203-212.
8. Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008;52(3):595-605.
9. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009;4(2):337-344.
10. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil-gelatinase-associated lipocalin and renal function after percutane ous coronary interventions. Am J Nephrol 2006;26(3):287-292.
11. Schilcher G, Ribitsch W, Otto R, et al. Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra- arterial angiography (ANTI-CIN Study). BMC Nephrol 2011;12:39.
12. Haase-Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery: a prospective cohort study. Crit Care Med 2009;37(2): 553-560.
13. Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 2008;3(1):273-280.
14. Erley CM. Does hydration prevent radiocontrast- induced acute renal failure? Nephrol Dial Transplant 1999;14(5): 1064-1066.
15. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291(19): 2328-2334.
16. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agentinduced reductions in renal function by acetylcysteine. N Engl J Med 2000;343(3): 180-184.
17. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145(4):247-254.
18. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105(19): 2259-2264.
19. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol 2003;14(8): 2178-2187.
20. Hoffmann U, Fischereder M, Krüger B, Drobnik W, Krämer BK. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004;15(2):407-410.
21. Ledneva E, Karie S, Launay-Vacher V, Janus N, Deray G. Renal safety of gadolinium- based contrast media in patients with chronic renal insufficiency. Radiology 2009;250(3):618-628.
22. Perazella MA. Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link? Clin J Am Soc Nephrol 2007;2(2):200-202.